Correlation Between BioCardia and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioCardia and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioCardia and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioCardia and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on BioCardia and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioCardia with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioCardia and Lipella Pharmaceuticals.
Diversification Opportunities for BioCardia and Lipella Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BioCardia and Lipella is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding BioCardia and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and BioCardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioCardia are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of BioCardia i.e., BioCardia and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioCardia and Lipella Pharmaceuticals
Assuming the 90 days horizon BioCardia is expected to under-perform the Lipella Pharmaceuticals. In addition to that, BioCardia is 2.2 times more volatile than Lipella Pharmaceuticals Common. It trades about -0.16 of its total potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.01 per unit of volatility. If you would invest 524.00 in Lipella Pharmaceuticals Common on August 31, 2024 and sell it today you would lose (213.00) from holding Lipella Pharmaceuticals Common or give up 40.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 25.98% |
| Values | Daily Returns |
BioCardia vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| BioCardia |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Lipella Pharmaceuticals |
BioCardia and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioCardia and Lipella Pharmaceuticals
The main advantage of trading using opposite BioCardia and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioCardia position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.The idea behind BioCardia and Lipella Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |